Health Condition 1: F330- Major depressive disorder, recurrent, mild
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adults aged between 18 and 35 years. 2. Individuals exhibiting mild depressive symptoms, as indicated by standardized assessment tools such as the Beck Depression Inventory II (BDI-II). 3. Adults with acute depression i.e. less than 6 months. 4. Participants who are not currently on psychiatric medication or has refused to take pharmaceutical treatment. 5. Individuals with normal or corrected-to-normal vision, to ensure optimal engagement with VR-based interventions. 6. Participants who demonstrate a willingness to engage with virtual reality (VR) equipment and comply with study procedures. 7. Individuals who are able to comprehend study instructions and provide informed consent independently. 8. Participants with a primary diagnosis of depression, irrespective of its etiology (e.g., situational, reactive, biological, or psychosocial origins). 9. Participants who can read and understand English language 10. Participants experiencing depression that is primarily situational or psychosocial in nature (e.g., resulting from academic stress, interpersonal difficulties, or occupational strain) will be included, whereas those whose depression is secondary to chronic medical illnesses or neurological conditions will be excluded
Exclusion criteria
Exclusion criteria: 1. Individuals presenting with moderate and severe depressive symptoms. 2. Adults with chronic depression i.e. more than 6 months. 3. History or diagnosis of neurological disorders (e.g., traumatic brain injury, stroke, or neurodegenerative conditions). 4. History of epilepsy, photosensitivity or motion sickness, due to potential contraindications with VR exposure. 5.Prior experience with virtual reality interventions or applications, to control for potential bias or habituation effects. 6. Individuals who are unable to comprehend study instructions and provide informed consent independently. 7. Presence of severe psychiatric comorbidities, including psychotic disorders, bipolar disorder, or substance use disorders. 8. Individuals who are unwilling or unable to participate in VR-based intervention sessions. 9. Participants with suicidal thoughts and abnormal cognitive or behavioral functioning.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Automatic thoughts questionnaire-negative (ATQ) 2. Beck Hopelessness Scale (BHS) 3. The Beck Depression Inventory-II (BDI-II) 4. Hamilton Depression Rating Scale (HDRS or HAM-D) 5. The Difficulties in Emotion Regulation Scale Short Form 6. Behavioral activation for depression scale Short Form (BADS-SF) 7. Social Interaction Anxiety Scale (SIAS) 8. Technostress Questionnaire 9. Cybersickness in Virtual Reality Questionnaire (CSQ-VR, 2023) Timepoint: During baseline, after intervention (after 4 weeks of full treatment) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Physiological Marker 1- Heart Rate Variability (HRV) 2. Physiological Marker- Blood PressureTimepoint: During baseline, after intervention (after 4 weeks of full treatment) | — |
Countries
India
Contacts
Punjabi University, Patiala